Skip to content

EBIT at other companies

Gevo logo
GevoGEVO
-$4.9M+75.7%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$71.37M+11.9%
NAG
Niagen Bioscience, Inc. Common StockNAGE
$1.58M-67.0%
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
$9.55M+54.7%
Opko Health logo
Opko HealthOPK
-$51.02M+24.0%
Upexi logo
UpexiUPXI
-$106.79M-2,877%

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-5.6%
Enterprise value$76.57M+1.0%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Calculated from EXOZ’s reported figures.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's EBIT?
EXOZ (EXOZ) reported EBIT of -$2.39M in Q1 2026.
How has EXOZ's EBIT changed year-over-year?
EXOZ's EBIT decreased by 22.4% year-over-year, from -$1.95M to -$2.39M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.